Skip to content

Author

A. D. Sidorova

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Modern glucose-lowering drugs SGLT2 inhibitors and GLP-1 agonists in the prevention of cardiovascular disease and dementia in patients with diabetes and metabolic disorders

A clinical pharmacological analysis of current data is presented, discussing the mechanisms of action, clinical efficacy, safety, and strategies for personalized use of SGLT2 inhibitors and GLP-1 RAs in preventing cardiovascular and neurodegenerative complications in patients with type 2 diabetes and metabolic disorder...

E. N. Saykina, A. O. Kenkishvili, M. Maksimov et al. · 0 citations
Review Sep 2026

Prevention and treatment strategy for onychomycosis: a guide for physicians and pharmacists

The authors examine the etiological profile (dominated by Trichophyton rubrum), risk factors, and key mechanisms of resistance, including the spread of Trichophyton indotineae, including the spread of Trichophyton indotineae.

Yu. A. Akulinina, M. Maksimov, A. Danilov et al. · 0 citations
Review Sep 2026

Topical and systemic therapy for onychomycosis: modern approaches and drug selection

This article presents a clinical-pharmacological overview of current approaches to treating onychomycosis, the most common fungal nail infection, with a global prevalence of approximately 4–5.5%. It examines the epidemiology, etiological profile (characterized by the predominance of Trichophyton rubrum and an increasin...

M. Maksimov, Yu. A. Akulinina, A. D. Sidorova et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.